The pharmaceutical industry has called for abolishing “off-year” drug price revisions in the run-up to the formulation of the 2024 Basic Policy on Economic and Fiscal Management and Reform (honebuto) later in June. It appears that its lobbying efforts have…
HOME > LATEST
LATEST
-
ORGANIZATION Only 3 Prefectures Log “Below 80%” Generic Rate in November: Kyokai Kenpo
April 10, 2024
-
REGULATORY Label Revision Ordered for 3 Beta Blockers to Delete Contraindication in Pregnant Women
April 10, 2024
-
BUSINESS Hypertension Therapy App Might Reduce Use of Antihypertensives: CureApp
April 10, 2024
-
REGULATORY Fanconi Syndrome Found in Majority of Health Damages Tied to Beni-Koji Supplements
April 10, 2024
-
BUSINESS Otsuka/Lundbeck Seek PTSD Nod for Rexulti in US
April 10, 2024
-
BUSINESS US FDA Grants Orphan Exclusivity for ALS Drug Radicava ORS
April 10, 2024
-
REGULATORY LDP Healthcare Clique Urges Rethink of Rationale for Off-Year Drug Price Revisions
April 10, 2024
-
BUSINESS R&D Jobs Make Up 40% of Pharma New Grads Hires This Spring, Sales Reps Only 20%: Poll
April 9, 2024
-
ORGANIZATION JPMA Launches Website Listing R&D Policies of Members to Help Foster Innovation Ecosystem
April 9, 2024
-
REGULATORY Lawmakers’ Group on Pollen Allergy to Compile Opinion Paper towards Honebuto
April 9, 2024
-
BUSINESS Toray Nets Positive Preclinical Data in Polymer-Conjugated Cancer Drug
April 9, 2024
-
BUSINESS Renalys Submits IND for Japan PIII Study of IgA Nephropathy Drug
April 9, 2024
-
REGULATORY LDP Generic League to Soon Draw Up Proposal towards Honebuto Policy
April 9, 2024
-
REGULATORY Japan Requests Self-Inspections for All Generic Firms; Report Due by October-End
April 9, 2024
-
BUSINESS Janssen Files Amivantamab Plus Lazertinib for NSCLC in Japan
April 9, 2024
-
BUSINESS Enhertu Nabs Pan-Tumor Indication in US: Daiichi Sankyo
April 9, 2024
-
BUSINESS GSK Japan Shooting for 80% Goal for Paid Paternity Leave in 2024
April 8, 2024
-
ORGANIZATION New LLP Coverage Scheme Intended for Generic Promotion: Payer Exec
April 8, 2024
-
BUSINESS Otsuka, Verily Join Forces to Run Mental Health Registry
April 8, 2024
-
ORGANIZATION Generic Rate Hits Record for 6th Straight Quarter in October-December: JGA
April 8, 2024
ページ
The pharmaceutical industry is ever-changing. Recruiters must evolve accordingly and prepare well in advance for future talent needs.This means predicting the changes and trends that will impact the market, industry, and your organization, and how this will affect talent requirements.…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…